Testing effectiveness (Phase 2)WithdrawnNCT00504491
What this trial is testing
R-CHOP and Alemtuzumab in Patients With Chronic Lymphocytic Leukemia
Who this might be right for
Chronic Lymphocytic LeukaemiaPatients Resistant to a Purine AnalogousPatients Relapsed With Purines Therapy
CABYC